A review on clinical, pathological characteristics and drug designing for COVID-19

References

• Adem, S., Eyupoglu, V., Sarfraz, I., Rasul, A., & Ali, M. (2020). Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: An in silico strategy unveils a hope against CORONA. Preprints. doi:https://doi.org/10.20944/preprints202003.0333.v1
   Google Scholar
• Alanagreh, L. A., Alzoughool, F., & Atoum, M. (2020). The human coronavirus disease COVID-19: Its origin, characteristics, and insights into potential drugs and its mechanisms. Pathogens, 9(5), 331. doi:https://doi.org/10.3390/pathogens9050331
   Web of Science ®Google Scholar
• Alsuliman, T., Sulaiman, R., Ismail, S., Srour, M., & Alrstom, A. (2020). COVID-19 paraclinical diagnostic tools: Updates and future trends. Current Research in Translational Medicine, 68(3), 83–91. doi:https://doi.org/10.1016/j.retram.2020.06.001
   Web of Science ®Google Scholar
• Al-Tawfiq, J. A., Al-Homoud, A. H., & Memish, Z. A. (2020). Remdesivir as a possible therapeutic option for the COVID-19. Travel Medicine and Infectious Disease, 34, 101615. doi:https://doi.org/10.1016/j.tmaid.2020.101615
   PubMed Web of Science ®Google Scholar
• Aly, O. M. (2020). Molecular docking reveals the potential of aliskiren, dipyridamole, mopidamol, rosuvastatin, rolitetracycline and metamizole to inhibit COVID-19 virus main protease. ChemRxiv, Preprint. doi:https://doi.org/10.26434/chemrxiv.12061302.v1
   Google Scholar
• Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science (New York, N.Y.), 300(5626), 1763–1767. doi:https://doi.org/10.1126/science.1085658
   PubMed Web of Science ®Google Scholar
• Anderson, A. C. (2003). The process of structure-based drug design. Chemistry & Biology, 10(9), 787–797. doi:https://doi.org/10.1016/j.chembiol.2003.09.002
   PubMed Web of Science ®Google Scholar
• Belouzard, S., Chu, V. C., & Whittaker, G. R. (2009). Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proceedings of the National Academy of Sciences of the United States of America, 106(14), 5871–5876. doi:https://doi.org/10.1073/pnas.0809524106
   PubMed Web of Science ®Google Scholar
• Bogoch, I. I., Watts, A., Thomas-Bachli, A., Huber, C., Kraemer, M. U., & Khan, K. (2020). Pneumonia of unknown etiology in Wuhan, China: Potential for international spread via commercial air travel. Journal of Travel Medicine, 27(2), taaa008. doi:https://doi.org/10.1093/jtm/taaa008
   PubMed Web of Science ®Google Scholar
• Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., … Li, X. (2020). A trial of lopinavir–ritonavir in adults hospitalized with severe COVID-19. New England Journal of Medicine, 382(19), 1787–1799. doi:https://doi.org/10.1056/NEJMoa2001282
   PubMed Web of Science ®Google Scholar
• Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, evaluation and treatment coronavirus (COVID-19). In Statpearls [internet]. Treasure Island, FL: StatPearls Publishing.
   Google Scholar
• Chang, Y. C., Tung, Y. A., Lee, K. H., Chen, T. F., Hsiao, Y. C., Chang, H. C., … Shih, S. S. (2020). Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking. Preprints. doi:https://doi.org/10.20944/preprints202002.0242.v1
   Google Scholar
• Channappanavar, R., & Perlman, S. (2017). Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. In Seminars in immunopathology (Vol. 39, No. 5, pp. 529–539). Berlin, Heidelberg: Springer. doi:https://doi.org/10.1007/s00281-017-0629-x
   Google Scholar
• China News Network. (2020, February 5). The team of Li Lanjuan: Abidor and Darunavir can effectively inhibit coronavirus. Retrieved from http://www.sd.chinanews.com/2/2020/0205/70145.html
   Google Scholar
• Chu, C. M., Cheng, V. C. C., Hung, I. F. N., Wong, M. M. L., Chan, K. H., Chan, K. S., … Peiris, J. S. M. (2004). Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax, 59(3), 252–256. doi:https://doi.org/10.1136/thorax.2003.012658
   PubMed Web of Science ®Google Scholar
• Cockrell, A. S., Beall, A., Yount, B., & Baric, R. (2017). Efficient reverse genetic systems for rapid genetic manipulation of emergent and preemergent infectious coronaviruses. In Reverse genetics of RNA viruses (pp. 59–81). New York, NY: Humana Press.
   Google Scholar
• Coleman, C. M., Sisk, J. M., Mingo, R. M., Nelson, E. A., White, J. M., & Frieman, M. B. (2016). Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion. Journal of Virology, 90(19), 8924–8933. doi:https://doi.org/10.1128/JVI.01429-16
   PubMed Web of Science ®Google Scholar
• de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., … Snijder, E. J. (2014). Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrobial Agents and Chemotherapy, 58(8), 4875–4884. doi:https://doi.org/10.1128/AAC.03011-14
   PubMed Web of Science ®Google Scholar
• de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016). SARS and MERS: Recent insights into emerging coronaviruses. Nature Reviews. Microbiology, 14(8), 523–534. doi:https://doi.org/10.1038/nrmicro.2016.81
   PubMed Web of Science ®Google Scholar
• Dorward, J., & Gbinigie, K. (2020). Lopinavir/ritonavir: A rapid review of effectiveness in COVID-19.
   Google Scholar
• Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics. doi:https://doi.org/10.1080/07391102.2020.1758791
   Web of Science ®Google Scholar
• Falzarano, D., De Wit, E., Martellaro, C., Callison, J., Munster, V. J., & Feldmann, H. (2013). Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin. Scientific Reports, 3, 1686. doi:https://doi.org/10.1038/srep01686
   PubMed Web of Science ®Google Scholar
• Farag, A., Wang, P., Ahmed, M., & Sadek, H. (2020). Identification of FDA approved drugs targeting COVID-19 virus by structure-based drug repositioning. ChemRxiv, Preprint. doi:https://doi.org/10.26434/chemrxiv.12003930.v1
   Google Scholar
• Fehr, A. R., & Perlman, S. (2015). Coronaviruses: An overview of their replication and pathogenesis. In Coronaviruses (pp. 1–23). New York, NY: Humana Press.
   Google Scholar
• Ferron, F., Subissi, L., De Morais, A. T. S., Le, N. T. T., Sevajol, M., Gluais, L., … Imbert, I. (2018). Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA. Proceedings of the National Academy of Sciences of the United States of America, 115(2), E162–E171. doi:https://doi.org/10.1073/pnas.1718806115
   Web of Science ®Google Scholar
• Gendrot, M., Javelle, E., Le Dault, E., Clerc, A., Savini, H., & Pradines, B. (2020). Chloroquine as prophylactic agent against COVID-19? International Journal of Antimicrobial Agents, 55(6), 105980. doi:https://doi.org/10.1016/j.ijantimicag.2020.105980
   Web of Science ®Google Scholar
• Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., … Nicastri, E. (2020). Compassionate use of remdesivir for patients with severe COVID-19. New England Journal of Medicine, 382(24), 2327–2336. doi:https://doi.org/10.1056/NEJMoa2007016
   PubMed Web of Science ®Google Scholar
• Hamming, I., Timens, W., Bulthuis, M. L. C., Lely, A. T., Navis, G. J., & van Goor, H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology, 203(2), 631–637. doi:https://doi.org/10.1002/path.1570
   PubMed Web of Science ®Google Scholar
• Hart, B. J., Dyall, J., Postnikova, E., Zhou, H., Kindrachuk, J., Johnson, R. F., … Hensley, L. (2014). Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. The Journal of General Virology, 95(Pt 3), 571–577. doi:https://doi.org/10.1099/vir.0.061911-0
   PubMedGoogle Scholar
• Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., … Diaz, G. (2020). First case of 2019 novel coronavirus in the United States. New England Journal of Medicine, 382(10), 929–936.
   PubMed Web of Science ®Google Scholar
• Ibrahim, I. M., Abdelmalek, D. H., Elshahat, M. E., & Elfiky, A. A. (2020). COVID-19 spike-host cell receptor GRP78 binding site prediction. Journal of Infection, 80(5), 554–562. doi:https://doi.org/10.1016/j.jinf.2020.02.026
   PubMed Web of Science ®Google Scholar
• Jeffers, S. A., Tusell, S. M., Gillim-Ross, L., Hemmila, E. M., Achenbach, J. E., Babcock, G. J., … Ambrosino, D. M. (2004). CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proceedings of the National Academy of Sciences of the United States of America, 101(44), 15748–15753. doi:https://doi.org/10.1073/pnas.0403812101
   PubMed Web of Science ®Google Scholar
• Jiang, F., Deng, L., Zhang, L., Cai, Y., Cheung, C. W., & Xia, Z. (2020). Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). Journal of General Internal Medicine, 35(5), 1545–1545. doi:https://doi.org/10.1007/s11606-020-05762-w
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., … Duan, Y. (2020). Structure of Mpro from COVID-19 virus and discovery of its inhibitors. bioRxiv, Preprint. doi:https://doi.org/10.1101/2020.02.26.964882
   Google Scholar
• Khaerunnisa, S., Kurniawan, H., Awaluddin, R., Suhartati, S., & Soetjipto, S. (2020). Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprint. doi:https://doi.org/10.20944/preprints202003.0226.v1
   Google Scholar
• Khalili, J. S., Zhu, H., Mak, N. S. A., Yan, Y., & Zhu, Y. (2020). Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19. Journal of Medical Virology, 92(7), 740–746. doi:https://doi.org/10.1002/jmv.25798
   PubMed Web of Science ®Google Scholar
• Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020). Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis, 10(2), 102–108. doi:https://doi.org/10.1016/j.jpha.2020.03.001
   PubMed Web of Science ®Google Scholar
• Liu, J., Wu, P., Gao, F., Qi, J., Kawana-Tachikawa, A., Xie, J., … Gao, G. F. (2010). Novel immunodominant peptide presentation strategy: A featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein. Journal of Virology, 84(22), 11849–11857. doi:https://doi.org/10.1128/JVI.01464-10
   PubMed Web of Science ®Google Scholar
• Liu, M., Jin, Z., Du, X., Xu, Y., Deng, Y., Zhao, Y., … Yu, J. (2020). Structure-based drug design, virtual screening and high-throughput screening rapidly identify antiviral leads targeting COVID-19. bioRxiv, Preprint.
   Google Scholar
• Lu, H., Stratton, C. W., & Tang, Y. W. (2020). Outbreak of pneumonia of unknown etiology in Wuhan China: The mystery and the miracle. Journal of Medical Virology, 92(4), 401–402. doi:https://doi.org/10.1002/jmv.25678
   PubMed Web of Science ®Google Scholar
• Macchiagodena, M., Pagliai, M., & Procacci, P. (2020). Identification of potential binders of the main protease 3CLpro of the COVID-19 via structure-based ligand design and molecular modeling. Chemical Physics Letters, 750, 137489. doi:https://doi.org/10.1016/j.cplett.2020.137489
   PubMed Web of Science ®Google Scholar
• Mercorelli, B., Palù, G., & Loregian, A. (2018). Drug repurposing for viral infectious diseases: how far are we? Trends in Microbiology, 26(10), 865–876. doi:https://doi.org/10.1016/j.tim.2018.04.004
   PubMed Web of Science ®Google Scholar
• Mousavizadeh, L., & Ghasemi, S. (2020). Genotype and phenotype of COVID-19: Their roles in pathogenesis. Journal of Microbiology, Immunology and Infection. doi:https://doi.org/10.1016/j.jmii.2020.03.022
   Google Scholar
• Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19. Journal of Biomolecular Structure and Dynamics. doi:https://doi.org/10.1080/07391102.2020.1752802
   PubMed Web of Science ®Google Scholar
• Perlman, S., & Netland, J. (2009). Coronaviruses post-SARS: Update on replication and pathogenesis. Nature Reviews. Microbiology, 7(6), 439–450. doi:https://doi.org/10.1038/nrmicro2147
   PubMed Web of Science ®Google Scholar
• Phan, L. T., Nguyen, T. V., Luong, Q. C., Nguyen, T. V., Nguyen, H. T., Le, H. Q., … Pham, Q. D. (2020). Importation and human-to-human transmission of a novel coronavirus in Vietnam. The New England Journal of Medicine, 382(9), 872–874. doi:https://doi.org/10.1056/NEJMc2001272
   PubMed Web of Science ®Google Scholar
• Read, R. (2020). Flawed methods in “COVID-19: Attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism.” ChemRxiv, Preprint. doi:https://doi.org/10.26434/chemrxiv.12120912.v2
   Google Scholar
• Richman, D. D., Whitley, R. J. and Hayden, F. G. (Eds.). (2016). Clinical virology. Hoboken, NJ: John Wiley & Sons.
   Google Scholar
• Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 109, 102433. doi:https://doi.org/10.1016/j.jaut.2020.102433
   PubMed Web of Science ®Google Scholar
• Sallard, E., Lescure, F. X., Yazdanpanah, Y., Mentre, F., Peiffer-Smadja, N., Florence, A. D. E. R., … Bouadma, L. (2020). Type 1 interferons as a potential treatment against COVID-19. Antiviral Research, 178, 104791. doi:https://doi.org/10.1016/j.antiviral.2020.104791
   PubMed Web of Science ®Google Scholar
• Shaghaghi, N. (2020). Molecular docking study of novel COVID-19 protease with low risk terpenoides compounds of plants. ChemRxiv, Preprint. doi:https://doi.org/10.26434/chemrxiv.11935722.v1
   Google Scholar
• Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., … Spahn, J. E. (2020). Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nature Communications, 11(1), 1–14. doi:https://doi.org/10.1038/s41467-019-13940-6
   PubMed Web of Science ®Google Scholar
• Singhal, T. (2020). A review of coronavirus disease-2019 (COVID-19). Indian Journal of Pediatrics, 87(4), 281–286. doi:https://doi.org/10.1007/s12098-020-03263-6
   PubMed Web of Science ®Google Scholar
• Sohrabi, C., Alsafi, Z., O'Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., … Agha, R. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 76, 71–76. doi:https://doi.org/10.1016/j.ijsu.2020.02.034
   PubMed Web of Science ®Google Scholar
• Song, F., Shi, N., Shan, F., Zhang, Z., Shen, J., Lu, H., … Shi, Y. (2020). Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology, 295(1), 210–217. doi:https://doi.org/10.1148/radiol.2020200274
   PubMed Web of Science ®Google Scholar
• Sui, J., Deming, M., Rockx, B., Liddington, R. C., Zhu, Q. K., Baric, R. S., & Marasco, W. A. (2014). Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness. Journal of Virology, 88(23), 13769–13780. doi:https://doi.org/10.1128/JVI.02232-14
   PubMed Web of Science ®Google Scholar
• Tang, F., Quan, Y., Xin, Z. T., Wrammert, J., Ma, M. J., Lv, H., … Cao, W. C. (2011). Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: A six-year follow-up study. Journal of Immunology, 186(12), 7264–7268. doi:https://doi.org/10.4049/jimmunol.0903490
   PubMed Web of Science ®Google Scholar
• Thiel, V., Ivanov, K. A., Putics, A., Hertzig, T., Schelle, B., Bayer, S., … Gorbalenya, A. E. (2003). Mechanisms and enzymes involved in SARS coronavirus genome expression. The Journal of General Virology, 84(Pt 9), 2305–2315. doi:https://doi.org/10.1099/vir.0.19424-0
   PubMed Web of Science ®Google Scholar
• Totura, A. L., & Bavari, S. (2019). Broad-spectrum coronavirus antiviral drug discovery. Expert Opinion on Drug Discovery, 14(4), 397–412. doi:https://doi.org/10.1080/17460441.2019.1581171
   PubMed Web of Science ®Google Scholar
• Tyrrell, D. A., & Myint, S. H. (1996). Coronaviruses. In Medical Microbiology (4th ed.). Galveston, TX: University of Texas Medical Branch at Galveston.
   Google Scholar
• ul Qamar, M. T., Alqahtani, S. M., Alamri, M. A., & Chen, L. L. (2020). Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis, 10(4), 313–319.
   PubMed Web of Science ®Google Scholar
• Victoria, R. (2020). 3D visualization of COVID-19 surface released for researchers. Drug Target Reviews.
   Google Scholar
• Walls, A. C., Park, Y. J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 181(2), 281–292.e6. doi:https://doi.org/10.1016/j.cell.2020.02.058
   PubMed Web of Science ®Google Scholar
• Wenzhong, L., & Hualan, L. (2020). COVID-19: Attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. ChemRxiv, Preprint. doi:https://doi.org/10.26434/chemrxiv.11938173.v6
   Google Scholar
• Wu, C. Y., Jan, J. T., Ma, S. H., Kuo, C. J., Juan, H. F., Cheng, Y. S. E., … Liang, F. S. (2004). Small molecules targeting severe acute respiratory syndrome human coronavirus. Proceedings of the National Academy of Sciences of the United States of America, 101(27), 10012–10017. doi:https://doi.org/10.1073/pnas.0403596101
   PubMed Web of Science ®Google Scholar
• Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., … Gao, G. F. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195. doi:https://doi.org/10.1073/pnas.1835675100
   PubMed Web of Science ®Google Scholar
• Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W., … Chen, H. D. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. doi:https://doi.org/10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar